China Botanic Pharmaceutical (CBP) Reports Q1 Earnings of $0.33/Share; Reaffirms Outlook

China Botanic Pharmaceutical (NYSE: CBP) reported Q1 EPS of $0.33, versus $0.29 reported last year. Revenue for the quarter came in at $28.1 million, versus $22.6 million reported last year.

China Botanic Pharmaceutical reaffirmed FY2012 guidance.

For earnings history and earnings-related data on China Botanic Pharmaceutical (CBP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c